Terms: = Breast cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6 AND Prognosis
5 results:
1. Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.
Zhao Q; Li Y; Wang T
Medicine (Baltimore); 2023 Oct; 102(41):e35439. PubMed ID: 37832099
[TBL] [Abstract] [Full Text] [Related]
2. A strengthening the reporting of observational studies in epidemiology (STROBE): Are he4 and CA 125 suitable to detect a Paget disease of the vulva?
Dellino M; Gargano G; Tinelli R; Carriero C; Minoia C; Tetania S; Silvestris E; Loizzi V; Paradiso A; Casamassima P; Tufaro A; Cormio G; Garrisi VM
Medicine (Baltimore); 2021 Feb; 100(5):e24485. PubMed ID: 33592901
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of human epididymal secretory protein 4 expression according to the molecular subtypes (luminal A, luminal B, human epidermal growth factor receptor 2-positive, triple-negative) of breast cancer.
Akoz G; Diniz G; Ekmekci S; Ekin ZY; Uncel M
Indian J Pathol Microbiol; 2018; 61(3):323-329. PubMed ID: 30004048
[TBL] [Abstract] [Full Text] [Related]
4. Preparation and characterization of a high-affinity monoclonal antibody against human epididymis protein-4.
Shen Y; Wang Y; Jiang X; Lu L; Wang C; Luo W; Zhang Y; Li P; Du Z; Dai T; Wu C; Fang A; Yao Y; Peng Q; Yang J
Protein Expr Purif; 2018 Jan; 141():44-51. PubMed ID: 28928083
[TBL] [Abstract] [Full Text] [Related]
5. he4 expression can be associated with lymph node metastases and disease-free survival in breast cancer.
Kamei M; Yamashita S; Tokuishi K; Hashioto T; Moroga T; Suehiro S; Ono K; Miyawaki M; Takeno S; Yamamoto S; Kawahara K
Anticancer Res; 2010 Nov; 30(11):4779-83. PubMed ID: 21115941
[TBL] [Abstract] [Full Text] [Related]